Pharmaids Pharmaceuticals Fair Value
Pharmaids Pharmaceuticals fair value. Pharmaids Pharmaceuticals (PHARMAID) average fair value is ₹20.57 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹30.21 (-31.91%), fair value range ₹7.95–₹40.05. For live price and a broader fundamental view, visit Pharmaids Pharmaceuticals share price chart.
Fair Value Analysis Export
PHARMAID Fair Value vs Current Price — Valuation Summary
PHARMAID average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. Explore PHARMAID intrinsic value to estimate fundamental worth using multiple valuation models.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
PHARMAID Fair Value Analysis — Data Sources & Coverage
Pharmaids Pharmaceuticals financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. Check Pharmaids Pharmaceuticals networth to track the company's total market size over time.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
PHARMAID vs Healthcare Sector Peers — P/E, P/B & Market Cap
Pharmaids Pharmaceuticals P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Emcure Pharmaceuticals | EMCURE | 35.85 | 7.38 | ₹37,156 |
| Divis Laboratories | DIVISLAB | 84.36 | 14.72 | ₹244,125 |
| Aurobindo Pharma | AUROPHARMA | 25.97 | 2.54 | ₹96,479 |
| Syngene International | SYNGENE | 65.37 | 2.98 | ₹14,538 |
| Sat Kartar Life | SATKARTAR | 16.56 | 4.14 | ₹307 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.